Bachelor of Science in Chemical Engineering (University of Detroit)
Bob Finder has more than 35 years’ experience in the international pharmaceutical and chemical industries. He recently retired as Chief Executive Officer of Novozymes GroPep Limited, the Australian subsidiary of Novozymes, a global biotechnology company. Bob was Managing Director and CEO of GroPep from 2002-06 (before the Novozymes acquisition).
Prior to joining GroPep in 2002, Bob was President and Chief Operating Officer of Mayne Pharma – Americas and Asia Pacific. In this role, Bob was responsible for commercial activities for the Americas and Asia Pacific region, as well as for global research and development for Mayne Pharma. Mayne Pharma evolved from Mayne’s acquisition of FH Faulding, where Bob was President and COO of Faulding Pharmaceuticals – Asia Pacific.
Prior to Faulding, Bob’s roles included Vice President Manufacturing for Ecogen Inc in Pennsylvania, Director Manufacturing for Rhone-Poulenc (USA), and Managing Director of Monsanto Chemicals in Thailand. He is a Member of the Australian Institute of Company Directors and the American Institute of Chemical Engineers, is on the board of directors of National Pharmacies, and is past Chairman of Reproductive Health Science Pty Ltd.
Commencement date: 23/04/2007
Chief Executive Officer and Managing Director
Master of Project Management (University of Adelaide), Diploma of Commerce (Sydney Institute of Business and Technology), Graduate, Australian Institute Of Company Directors (Australian Institute Of Company Directors).
After beginning his career with global defence contractor Thales, Brent spent 11 years gaining broad Senior Executive experience in a variety of roles with Australian medical device manufacturer Cochlear Limited. Having lead an important transformation project from within Cochlear’s Global Quality & Regulatory Group, Brent relocated to the United States working for Cochlear Americas where he held senior Operations and Sales roles based in Colorado and Texas. During this time he established a US Manufacturing subsidiary from ground up, where product was manufactured and business audited by the FDA with no observations. Mr Barnes returned to Sydney in 2011 to take up roles including Director, Recipient Services & Operations (Asia-Pacific) and General Manager, Asia Growth Markets and Operations Director (Asia Pacific), which saw him spending 50% of his time in Asia.
Brent is also a non-executive Director of Connek Pty Ltd, a Telecommunications & IT professional services company that subcontracts to major blue chip companies within the IT/T space.
In his spare time, Brent enjoys all sports and tries to keep fit. He’s a keen Aussie Rules follower, and a Life Member of Sydney’s North Shore Bombers AFC and during his US posting, he played Australian Rules football for the Denver Bulldogs.
Commencement date: 08/08/2016
Law Degree (University of Melbourne)
Kate Costello was in management with a commercial law firm before establishing a management consultancy specialising in corporate governance practices and board performance. Kate has over 20 years' experience in corporate governance and strategy through her consulting work with the boards of client organisations, her directorships, and her previous involvement as a facilitator in the Company Directors’ Course offered by the Australian Institute of Company Directors.
Kate’s board experience includes directorships in Integrated Research Ltd, the South Australian TAB, Australian Central Credit Union Ltd, and Festival City Broadcasters Ltd, and chairmanships of Saab Intelligent Transport Systems Ltd and Bassett Consulting Engineers. She currently holds directorships in Tech Project Pty Ltd and bzpay Pty Ltd and chairs accounting firm, Acrru Harris Orchard.
A regular public speaker on governance issues, Kate was a committee member for the independent review of the governance of soccer in Australia as well as a member of the University of Adelaide’s Independent Selection Committee. She is currently a fellow of the Institute of Company Directors, and a member of the Law Society of South Australia.
Commencement date: 12/08/2005
Law Degree (University of Adelaide)
Stephen Mathwin has more than 30 years’ experience as a legal practitioner, including being a partner with the Adelaide law firm, Kelly & Co, from 1988 to 2001. In that time he headed the firm’s Employment, Industrial Law and Superannuation Section, and was responsible for managing much of its internal risk management functions. He remains a consultant to Kelly & Co.
Stephen is Chairman of Australian Timbers Ltd, AEM Cores Pty Ltd, and Poly Products Co Pty Ltd. He is a director of Paragon Private Equity and its associated companies, the McArthur Management Group of Companies, and Albox Australia Pty Ltd.
Stephen is a former Deputy Chairman and Chairman of the Investment Committee of Non-Government Schools (NGS) Superannuation Fund, an industry fund with funds under management exceeding $5 billion. During his time at NGS, the fund grew from $1.6 billion to more than $5 billion. Stephen is also a former Chairman of the School Council of Westminster School Incorporated, and is Chairman of the Investment Committee for the Westminster School Foundation.
Commencement date: 15/11/2006
Bachelor of Medicine (University of the Witwatersrand, Johannesburg), Master of Public Health – Health Policy and Health Economics (Johns Hopkins University, Baltimore)
Caroline Popper is a US-based pathologist and business consultant, with more than 20 years’ operational experience in the international diagnostics, medical devices and drug discovery fields. After 10 years in senior management and marketing roles at Becton, Dickinson and Company, Caroline established her own consultancy company to provide strategic corporate and advisory services to businesses across the life sciences spectrum.
A qualified health economist, Caroline has served in senior managerial and advisory positions at a number of global diagnostics and medical research companies, including bioMérieux and MDS Proteomics, where she was Chief Business Officer from 2000 to 2002. As well as extensive corporate experience, Caroline enjoys a hands-on clinical perspective from her years as an attending physician at the Department of Emergency Medicine at Baltimore’s Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.
In 2003, Caroline founded Popper and Company, a strategy and M&A advisory firm focused on diagnostics, medical devices, life science tools, and wireless health applications. Her other directorships include Innovative Biosensors Inc (Chairman), nanoMR, Rarecyte and Pilgrim Software Inc.
Commencement date: 15/03/2012
CFO & Company Secretary
Masters Degree in Applied Finance (Kaplan), Masters Degree in Business Administration (University of Adelaide), Bachelor of Accountancy (University of South Australia)
Dan has worked as a director, CFO or company secretary for a variety of companies in the construction, technology and financial services sectors. His current non-executive directorships include power industry supplier AEM Cores and ultrasound technology developer Cavitus Pty Ltd. Both companies are high growth, export focused businesses of whom sell globally into more than 30 countries.
Previously, Dan had spent six years in private equity as an Investment Manager with Paragon Private Equity, a $34m buyout and expansion capital fund, and spent five years working in London across various sectors in international financial reporting and project management roles.
Dan is a Chartered Accountant, Fellow of FINSIA and a certificated member of the Governance Institute of Australia.